How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease? A narrative review about possible therapeutic and preventive strategies

References

• Global strategy for the diagnosis, management, and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2019. [citeed 2019 Aug 1]. Available from: http://goldcopd.org
   Google Scholar
• National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management; 2010. [cited 2019 Aug 1]. Available from: https://www.nice.org.uk/guidance/CG101
   Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963.
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129:536–544.
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Xie H, Etminan M, et al. Canadian Respiratory Research Network. The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: updating the literature using robust statistical methodology. PLoS One. 2018;13(1):e0191243.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anzueto AR, Dusser D, et al. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1297–1308.
   PubMed Web of Science ®Google Scholar
• Blasi F, Cesana G, Conti S, et al. The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients. PLoS One. 2014;9(6):e101228.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Barbeta E, Ielpo A, et al. Management of severe acute exacerbations of COPD: an updated narrative review. Multidiscip Respir Med. 2018;13:36.
   PubMed Web of Science ®Google Scholar
• Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29(6):1224–1238.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Torres A. Hospitalized acute exacerbations of chronic obstructive pulmonary disease: which patients may have a negative clinical outcome? Expert Rev Respir Med. 2019;13(8):691–693.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Torres A, Huerta A, et al. Predicting in-hospital treatment failure (≤7 days) in patients with COPD exacerbation using antibiotics and systemic steroids. COPD. 2016;13(1):82–92.
   PubMedGoogle Scholar
• Soler N, Esperatti M, Ewig S, et al. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J. 2012;40(6):1344–1353.
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365.
   PubMed Web of Science ®Google Scholar
• Rangelov K, Sethi S. Role of infections. Clin Chest Med. 2014;35(1):87–100.
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465–471.
   PubMed Web of Science ®Google Scholar
• Li XJ, Li Q, Si LY, et al. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respir Care. 2011;56(11):1818–1824.
   PubMed Web of Science ®Google Scholar
• Estirado C, Ceccato A, Guerrero M, et al. Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease. Respir Res. 2018;19(1):119.
   PubMedGoogle Scholar
• Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.
   PubMedGoogle Scholar
• Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, et al. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev. 2017;26(143):pii: 160073.
   PubMed Web of Science ®Google Scholar
• Wang JX, Zhang SM, Li XH, et al. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Int J Infect Dis. 2016;48:40–45.
   PubMed Web of Science ®Google Scholar
• Li Z, Yuan X, Yu L, et al. Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: an updated meta-analysis. Medicine (Baltimore). 2019;98(32):e16775.
   PubMed Web of Science ®Google Scholar
• Ulrich RJ, McClung D, Wang BR, et al. Introduction of procalcitonin testing and antibiotic utilization for acute exacerbations of chronic obstructive pulmonary disease. Infect Dis (Auckl). 2019;12:1178633719852626.
   Google Scholar
• Vollenweider DJ, Frei A, Steurer-Stey CA, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;10:CD010257.
   PubMedGoogle Scholar
• Vermeersch K, Gabrovska M, Aumann J, et al. Azithromycin during acute chronic obstructive pulmonary disease exacerbations requiring hospitalization (BACE). A multicenter, randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2019;200(7):857–868.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European respiratory society/American thoracic society guideline. Eur Respir J. 2017;49(3):pii: 1600791.
   PubMed Web of Science ®Google Scholar
• Woods JA, Wheeler JS, Finch CK, et al. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:421–430.
   PubMed Web of Science ®Google Scholar
• Walters JAE, Tan DJ, White CJ, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;348:CD001288.
   Google Scholar
• de Jong YP, Uil SM, Grotjohan HP, et al. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest. 2007;132(6):1741–1747.
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309(21):2223–2231.
   PubMed Web of Science ®Google Scholar
• Sivapalan P, Lapperre TS, Janner J, et al. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial. Lancet Respir Med. 2019;7(8):699–709.
   PubMed Web of Science ®Google Scholar
• Osadnik CR, Tee VS, Carson-Chahhoud KV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:CD004104.
   PubMed Web of Science ®Google Scholar
• Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014;14:19.
   PubMed Web of Science ®Google Scholar
• Marchioni A, Castaniere I, Tonelli R, et al. Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation. Crit Care. 2018;22(1):109.
   PubMedGoogle Scholar
• Ergan B, Ergün R. Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study. Int J Chron Obstruct Pulmon Dis. 2016;11:1775–1783.
   PubMed Web of Science ®Google Scholar
• Ko BS, Ahn S, Lim KS, et al. Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure. Intern Emerg Med. 2015;10(7):855–860.
   PubMed Web of Science ®Google Scholar
• Antonaglia V, Ferluga M, Molino R, et al. Comparison of noninvasive ventilation by sequential use of mask and helmet versus mask in acute exacerbation of chronic obstructive pulmonary disease: a preliminary study. Respiration. 2011;82(2):148–154.
   PubMed Web of Science ®Google Scholar
• Nicolini A, Santo M, Ferrari-Bravo M, et al. Open-mouthpiece ventilation versus nasal mask ventilation in subjects with COPD exacerbation and mild to moderate acidosis: a randomized trial. Respir Care. 2014;59(12):1825–1831.
   PubMed Web of Science ®Google Scholar
• Di Marco F, Centanni S, Bellone A, et al. Optimization of ventilator setting by flow and pressure waveforms analysis during noninvasive ventilation for acute exacerbations of COPD: a multicentric randomized controlled trial. Crit Care. 2011;15(6):R283.
   PubMed Web of Science ®Google Scholar
• Bhatti H, Ramdass A, Cury JD, et al. Operator dependent factors implicated in failure of non-invasive positive pressure ventilation (NIPPV) for respiratory failure. Clin Respir J. 2017;11(6):901–905.
   PubMed Web of Science ®Google Scholar
• Mulpuru S, McKay J, Ronksley PE, et al. Factors contributing to high-cost hospital care for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:989–995.
   PubMed Web of Science ®Google Scholar
• Wang Y, Stavem K, Dahl FA, et al. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014;9:99–105.
   PubMed Web of Science ®Google Scholar
• De la Iglesia F, Valiño P, Pita S, et al. Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease. J Intern Med. 2002;251(6):500–507.
   PubMed Web of Science ®Google Scholar
• Quintana JM, Unzurrunzaga A, Garcia-Gutierrez S, et al. IRYSS-COPD group. Predictors of hospital length of stay in patients with exacerbations of COPD: a cohort study. J Gen Intern Med. 2015;30(6):824–831.
   PubMed Web of Science ®Google Scholar
• Tsimogianni AM, Papiris SA, Stathopoulos GT, et al. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med. 2009;24(9):1043–1048.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Ielpo A, Barbeta E, et al. Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study. Respir Res. 2018;19(1):261.
   PubMed Web of Science ®Google Scholar
• Gadre SK, Duggal A, Mireles-Cabodevila E, et al. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD). Medicine (Baltimore). 2018;97(17):e0487.
   PubMed Web of Science ®Google Scholar
• Terzano C, Colamesta V, Unim B, et al. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur Rev Med Pharmacol Sci. 2017;21(16):3680–3689.
   PubMed Web of Science ®Google Scholar
• Diamantea F, Kostikas K, Bartziokas K, et al. Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score. Respir Care. 2014;59(11):1679–1686.
   PubMed Web of Science ®Google Scholar
• Ferreira L, Moniz AC, Carneiro AS, et al. The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. Diabetes Metab Syndr. 2019;13(1):149–153.
   PubMed Web of Science ®Google Scholar
• Gulati S, Zouk AN, Kalehoff JP, et al. The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:2271–2278.
   PubMed Web of Science ®Google Scholar
• Pendharkar SR, Ospina MB, Southern DA, et al. Effectiveness of a standardized electronic admission order set for acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med. 2018;18(1):93.
   PubMedGoogle Scholar
• Brown KE, Johnson KJ, DeRonne BM, et al. Order set to improve the care of patients hospitalized for an exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(6):811–815.
   PubMed Web of Science ®Google Scholar
• Parikh R, Shah TG, Tandon R. COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates. Int J Chron Obstruct Pulmon Dis. 2016;11:577–583.
   PubMed Web of Science ®Google Scholar
• Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354(9177):456–460.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N Engl J Med. 1999;340(25):1941–1947.
   PubMed Web of Science ®Google Scholar
• Kiser TH, Allen RR, Valuck RJ, et al. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:1052–1064.
   PubMed Web of Science ®Google Scholar
• Alia I, de la Cal MA, Esteban A, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med. 2011;171:1939–1946.
   PubMed Web of Science ®Google Scholar
• Abroug F, Ouanes-Besbes L, Fkih-Hassen M, et al. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J. 2014;43(3):717–724.
   PubMed Web of Science ®Google Scholar
• Nouira S, Marghli S, Besbes L, et al. Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease; a randomised trial of trimethoprim-sulfamethoxazole versus ciprofloxacin. Clin Infect Dis. 2010;51:143–149.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, et al. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J. 2011;37(3):508–515.
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2):81–89.
   PubMedGoogle Scholar
• Trethewey SP, Edgar RG, Morlet J, et al. Temporal trends in survival following ward-based NIV for acute hypercapnic respiratory failure in patients with COPD. Clin Respir J. 2019;13(3):184–188.
   PubMed Web of Science ®Google Scholar
• Fruchter O, Yigla M, Kramer MR. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation. Am J Med Sci. 2015;349(1):29–35.
   PubMed Web of Science ®Google Scholar
• Vallabhajosyula S, Haddad TM, Sundaragiri PR, et al. Role of B-type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5-year retrospective analysis. J Intensive Care Med. 2018;33(11):635–644.
   PubMed Web of Science ®Google Scholar
• Vallabhajosyula S, Sundaragiri PR, Kanmanthareddy A, et al. Influence of left ventricular hypertrophy on in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease. COPD. 2016;13(6):712–717.
   PubMedGoogle Scholar
• Chalela R, González-García JG, Chillarón JJ, et al. Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations. Respir Med. 2016;117:237–242.
   PubMed Web of Science ®Google Scholar
• Brown H, Dodic S, Goh SS, et al. Factors associated with hospital mortality in critically ill patients with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:2361–2366.
   PubMed Web of Science ®Google Scholar
• Esteban C, Arostegui I, Garcia-Gutierrez S, et al. A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study. Respir Res. 2015;16:151.
   PubMed Web of Science ®Google Scholar
• Spece LJ, Donovan LM, Griffith MF, et al. Quality of care delivered to veterans with COPD exacerbation and the association with 30-day readmission and death. COPD. 2018;15(5):489–495.
   PubMedGoogle Scholar
• Cousse S, Gillibert A, Salaün M, et al. Efficacy of a home discharge care bundle after acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:289–296.
   PubMed Web of Science ®Google Scholar
• Kiser TH, Reynolds PM, Moss M, et al. Colorado Pulmonary Outcomes Research Group (CPOR). Impact of macrolide antibiotics on hospital readmissions and other clinically important outcomes in critically Ill Patients with acute exacerbations of chronic obstructive pulmonary disease: a propensity score-matched cohort study. Pharmacotherapy. 2019;39(3):242–252.
   PubMed Web of Science ®Google Scholar
• Guerrero M, Crisafulli E, Liapikou A, et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a long-term observational study. PLoS One. 2016;11(3):e0150737.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Guerrero M, Chetta A, et al. Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Eur Respir J. 2016;48(1):279–281.
   PubMedGoogle Scholar
• Crisafulli E, Ortega S, Torres A. Predictors of readmission in a period of 30 days or less in acute exacerbation of chronic obstructive pulmonary disease. Clin Pulm Med. 2015;22(4):172–176.
   Google Scholar
• Mantero M, Rogliani P, Di Pasquale M, et al. Acute exacerbations of COPD: risk factors for failure and relapse. Int J Chron Obstruct Pulmon Dis. 2017;12:2687–2693.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Guerrero M, Ielpo A, et al. Looking for predictors of early readmission in chronic obstructive pulmonary disease: every effort is required. Ann Am Thorac Soc. 2018;15(11):1366.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Torres A, Huerta A, et al. C-reactive protein at discharge, diabetes mellitus and ≥ 1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. COPD. 2015;12(3):306–314.
   PubMedGoogle Scholar
• Shah T, Press VG, Huisingh-Scheetz M, et al. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926.
   PubMed Web of Science ®Google Scholar
• Prieto-Centurion V, Markos MA, Ramey NI, et al. Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc. 2014;11(3):417–424.
   PubMedGoogle Scholar
• Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J. 2006;28(1):123–130.
   PubMed Web of Science ®Google Scholar
• Kwok T, Lum CM, Chan HS, et al. A randomized, controlled trial of an intensive community nurse-supported discharge program in preventing hospital readmissions of older patients with chronic lung disease. J Am Geriatr Soc. 2004;52:1240–1246.
   PubMed Web of Science ®Google Scholar
• Lavesen M, Ladelund S, Frederiksen AJ, et al. Nurse-initiated telephone follow-up on patients with chronic obstructive pulmonary disease improves patient empowerment, but cannot prevent readmissions. Dan Med J. 2016;63(10):pii: A5276.
   PubMed Web of Science ®Google Scholar
• Adamson SL, Burns J, Camp PG, et al. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:61–71.
   PubMed Web of Science ®Google Scholar
• Laverty AA, Elkin SL, Watt HC, et al. Impact of a COPD discharge care bundle on readmissions following admission with acute exacerbation: interrupted time series analysis. PLoS One. 2015;10(2):e0116187.
   PubMed Web of Science ®Google Scholar
• Moretti M, Fagnani S. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2015;10:2319–2325.
   PubMed Web of Science ®Google Scholar
• Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003;348(26):2618–2625.
   PubMed Web of Science ®Google Scholar